Authors/Disclosures
|
Andrew D. Goodman, MD, FAAN
(University of Rochester Dept. Neurology)
|
Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono. |
|
Theodore R. Brown, MD
(MS Center At Evergreen)
|
Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck. |
|
|
No disclosure on file |
|
Keith R. Edwards, MD, FAAN
(MS Center of Northeastern New York)
|
No disclosure on file |
|
|
No disclosure on file |
|
Lawrence Marinucci
(Acorda Therapeutics)
|
No disclosure on file |
|
Ron Cohen, MD
(Acorda Therapeutics)
|
Dr. Cohen has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for VBL Therapeutics. Dr. Cohen has stock in Acorda Therapeutics. |
|
Andrew Blight, PhD
(Acorda Therapeutics, Inc)
|
No disclosure on file |